This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (584) Substance Abuse (432) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (161)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43122, first published .
A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study

A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study

A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study

Authors of this article:

Hilary Luderer1 Author Orcid Image ;   Nicole Enman1 Author Orcid Image ;   Robert Gerwien1 Author Orcid Image ;   Stephen Braun1 Author Orcid Image ;   Samantha McStocker1 Author Orcid Image ;   Xiaorui Xiong1 Author Orcid Image ;   Carrington Koebele2 Author Orcid Image ;   Christopher Cannon2 Author Orcid Image ;   Joseph Glass3 Author Orcid Image ;   Yuri Maricich1 Author Orcid Image
Article Authors Cited by (3) Tweetations (3) Metrics

Journals

  1. Fogarty J. LOTUS Software to Process Wearable EmbracePlus Data. Sensors 2024;24(23):7462 View
  2. Fassbender A, Donde S, Silva M, Friganovic A, Stievano A, Costa E, Winders T, van Vugt J. Adoption of Digital Therapeutics in Europe. Therapeutics and Clinical Risk Management 2024;Volume 20:939 View